Animal models of mitral regurgitation induced by mitral valve chordae tendineae rupture

Aurelia A Leroux1, Marie L Moonen, Luc A Pierard

  • 1Department of Companion Animals and Equids, Faculty of Veterinary Medicine, University of Liege, Liège, Sart Tilman, Belgium. Aurelia.Leroux@ulg.ac.be

Abstract

Insights

Animal models using mitral valve chordae tendineae rupture, primarily in dogs and sheep, effectively replicate chronic mitral regurgitation (MR). These models aid in understanding MR pathophysiology and testing new therapies, despite high complication rates.

Area of Science:

  • Cardiovascular Research
  • Animal Models of Disease
  • Valvular Heart Disease

Background:

  • Mitral regurgitation (MR) is a prevalent global valvular disease.
  • Current treatments for chronic MR remain a subject of debate.
  • Animal models are crucial for studying MR pathophysiology and therapeutic strategies.

Purpose of the Study:

  • To review animal models of chronic mitral regurgitation (MR) induced by mitral valve chordae tendineae rupture.
  • To compare the advantages and disadvantages of different chordae tendineae rupture techniques.
  • To assess the utility of these models for understanding MR and evaluating new treatments.

Main Methods:

  • Review of existing literature on animal models of MR.
  • Focus on models utilizing mitral valve chordae tendineae rupture.
  • Comparison of closed-chest and open-chest surgical techniques.

Main Results:

  • Dogs and sheep are the most common animal models due to cardiac size.
  • Both closed- and open-chest techniques can induce MR via chordae tendineae rupture.
  • Induced MR becomes chronic within 3-6 months, with high reported mortality and complication rates.

Conclusions:

  • Animal models of MR via chordae tendineae rupture mimic the long-term progression of human chronic MR.
  • These models offer valuable insights into disease mechanisms.
  • They serve as platforms for testing novel therapeutic interventions for mitral regurgitation.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...